Catabasis Pharmaceuticals to raise about $110m in private placement

Catabasis Pharmaceuticals, a biopharmaceutical company, has inked about $110 million in a private placement.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this